Navigation Links
D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients
Date:5/6/2009

l protocol for a trial from which the data will form the primary basis for a claim of efficacy. In general, the SPA can significantly reduce development time since the design of the pivotal protocol has been approved in advance.

About DP-b99

DP-b99 is a unique neuroprotective drug that addresses an array of brain damaging processes occurring in stroke patients and emerged from D-Pharm's proprietary Membrane Activated Chelator (MAC) platform technology. D-Pharm successfully completed extensive testing of DP-b99 in pre-clinical and then in Phase I and Phase II clinical studies. Both preclinical and clinical studies indicate a favorable efficacy and safety profile for DP-b99. In the recently completed Phase IIb trial in 150 ischemic stroke patients, DP-b99 increased by two-fold the percentage of patients that completely recovered from ischemic stroke. DP-b99 may be administered within a nine hour therapeutic window.

About Stroke

Every year approximately 780,000 Americans have a new or recurrent stroke. The second most common cause of death worldwide, stroke is also the leading cause of serious long-term disability; 15% to 30% of stroke survivors experience permanent disability. According to the American Heart Association, the estimated direct and indirect cost in 2009 of stroke in the US is $68.9 billion. Other than tissue plasminogen activator (tPA), which must be administered 3 hours after stroke, there are no FDA approved medicines for this indication.

About D-Pharm Ltd.

D-Pharm (http://www.dpharm.com) is a clinical stage, biopharmaceutical company pioneering the development of lipid-like therapeutics and has generated a rich pipeline of patent protected proprietary products. D-Pharm's pipeline includes advanced clinical stage products DP-b99 for treatment of acute ischemic stroke patients and DP-VPA, a novel dr
'/>"/>

SOURCE D-Pharm Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
2. U.S. Naval Medical Research Center Resubmits IND Application for Proposed RESUS Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
3. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
4. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
5. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
6. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
7. Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
8. U.S. Naval Medical Research Center Resubmits IND Application for Proposed Op RESUS Clinical Trial in Trauma Patients in the Battlefield Setting
9. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
10. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
11. U.S. Navy Submits Protocol for Field Trauma Trial of Hemopure(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...if.,Nov.23/PRNewswire-FirstCall/--TransceptPharmac...scheduledtomeetwiththeU.S.FoodandDrugAdministratio...LetterregardingtheNewDrugApplication(NDA)for Inter...spreviouslyannounced,theCompleteResponseLetter,rec...DAcouldnotapprovetheNDAinitspresentform.TheNDAseek...
(Date:11/23/2009)...ov.23/PRNewswire/--LigonDiscovery,Inc.,whichusespr...ugsagainsthigh-valuetargets,todayannouncedtheappoi...aasLigon,sExecutiveChairmanoftheBoard. ,, "I,mv...oftheBoard,"saidPatrickKleyn,Ligon,schiefexecutive...rienceinthelifesciencesindustry--particularlyhisle...
(Date:11/23/2009)...provalsoftwonewtherapiesforNon-Hodgkin,sLymphomas(...deofatumumab(Azerra(TM),GlaxoSmithKline)asatherapy...L)andromidepsin(Istodax(R),GloucesterPharmaceutica...celllymphoma(CTCL). ,, FORTWASHINGTON,Pa.,Nov.2...epromptedtheNationalComprehensiveCancerNetwork( NC...
Breaking Medicine Technology:Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter 2Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Precision Stability Storage Announces Upcoming Expansion 12665 1Precision Stability Storage Announces Upcoming Expansion 12665 2Precision Stability Storage Announces Upcoming Expansion 12665 3Allsup Medicare Advisor 28SM 29 Expands Service 3B Helps Seniors and People with Disabilities Make Best Medicare Choices 49155 1Allsup Medicare Advisor 28SM 29 Expands Service 3B Helps Seniors and People with Disabilities Make Best Medicare Choices 49155 2Allsup Medicare Advisor 28SM 29 Expands Service 3B Helps Seniors and People with Disabilities Make Best Medicare Choices 49155 3Allsup Medicare Advisor 28SM 29 Expands Service 3B Helps Seniors and People with Disabilities Make Best Medicare Choices 49155 4Allsup Medicare Advisor 28SM 29 Expands Service 3B Helps Seniors and People with Disabilities Make Best Medicare Choices 49155 5Autism Course Added to HealthForumOnline 26apos 3Bs Continuing Education 28CE 29 Website for Mental Health Professionals 26amp 3B Nurses 49151 1Autism Course Added to HealthForumOnline 26apos 3Bs Continuing Education 28CE 29 Website for Mental Health Professionals 26amp 3B Nurses 49151 2Autism Course Added to HealthForumOnline 26apos 3Bs Continuing Education 28CE 29 Website for Mental Health Professionals 26amp 3B Nurses 49151 3Autism Course Added to HealthForumOnline 26apos 3Bs Continuing Education 28CE 29 Website for Mental Health Professionals 26amp 3B Nurses 49151 4
...N, Mass., Aug. 26 Cambridge Research &,Instrument...stro(TM) EX In,Vivo Imaging System. The new system...gy and becomes the entry-level instrument of choic...p://www.newscom.com/cgi-bin/prnh/20080826/NETU054 ...ncement of CRi,s unique,solid-state tunable optics...
...LE, Aug. 26 Omeros Corporation today announced th...2 trial investigating,OMS103HP in arthroscopic ant...ry. OMS103HP is an investigational drug product th...d is designed to improve postoperative,knee functi... patients an,earlier return to work. The article t...
Other Medicine Technology:CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2
(Date:11/23/2009)...ion of arsenic compounds appears to cause oxidativ..., according to a new study published online Novemb...tute . , Although biomethylation was once believ...t to enhance its toxicity and potentially its carc...iomethylation in oxidative DNA damage in mice, Mic...
(Date:11/23/2009)...re. Low-income children who don,t access health c...term are significantly more likely to have unmet h... to a new study published in the journal Pediatri...ng the financing and delivery of quality health ca...the current policy debates about health insurance ...
(Date:11/23/2009)...ov. 23, 2009) -- A first-of-its-kind consensus sta...ay in the Annals of Surgery . The report illustra...sus conference -- Diabetes Surgery Summit (DSS) --...ntific and medical experts agreed on a set of evid...nt to guide the use and study of gastrointestinal ...
(Date:11/23/2009)...ee-quarters getting chemo deal with insomnia, stud...ews) -- Insomnia and sleep disorders affect more t...hemotherapy, a rate nearly three times higher than.... , The problem is more common in younger patie...d University of Rochester Medical Center researche...
(Date:11/23/2009)... Healy, first woman to head the agency, said lives...ealthDay News) -- The fallout from last week,s con...rt of routine mammogram testing for breast cancer ... Institutes of Health advising women to ignore the...re them, because unequivocally this will increase ...
Breaking Medicine News(10 mins):Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3
... Feb. 29 Richard P. Miller,of Marlton, president ...talled as chairman of the board of the New Jersey ... organization. The chairman,s official,installatio...ture of New Jersey,s hospitals, I am an optimist,"...
...9 WebMD Health Corp. (Nasdaq:,WBMD) and HLTH Corp...utives,of WebMD are scheduled to participate at th... March 4, 2007 at 4:35 pm ET., Investors, analyst...://www.wbmd.com (in the Investor Relations sectio...
...alif. A UC Riverside-led study in the Mojave Dese...ment have an unusually high concentration of nitra...le to erosion by rain and wind if the desert pavem...he March issue of Geology . , Desert pavement is...
...LEXINGTON, Ky., Feb. 29 Bringing with them signif...GIRD (Glenohumeral Internal,Rotation Deficit) in t...xington, Kentucky-based sports-medicine experts ha...20080229/CLF060 ), Both Dr. W. Ben Kibler, Medic...
...Needy Children and Adults to be Affected Nationwid...WASHINGTON, Feb. 29 A survey released today,by Sp... known,anti-privatization measure in the current f...d Farm Bill by Rep. Joe,Baca (D-CA), would restric...
...Needy Children and Adults to be Affected Nationwid...WASHINGTON, Feb. 29 /PRNewswire-USNewswire/ - A su...ions states that a little known,anti-privatization...amendment to the House-passed Farm Bill by Rep. Jo...
Other Medicine News:Health News:New Jersey Hospital Association Names New Chairman, Appoints Board Officers and New Members 2Health News:Large source of nitrate, a potential water contaminant, found in near-surface desert soils 2Health News:Large source of nitrate, a potential water contaminant, found in near-surface desert soils 3Health News:Kentucky-Based Sports Medicine Duo Invited to Astros' Spring Training Camp 2Health News:Farm Bill Provision Will Disrupt Kansas Medicaid Program 2Health News:Farm Bill Provision Will Disrupt Kansas Medicaid Program 3Health News:Farm Bill Provision Will Disrupt Delaware Medicaid Program 2Health News:Farm Bill Provision Will Disrupt Delaware Medicaid Program 3
Follicle Stimulating Hormone (FSH) Enzyme Immunoassay Test Kit
Anti-GBM-IgG
FSH Radioimmunoassay
...ne (FSH) is a glygoprotein produced by the anterio...as LH, TSH, and HCG, FSH consists of subunits desi... direct sandwich ELISA method. The samples and dil... coated with Mab to FSH beta subunit. FSH in the p...
Medicine Products: